Cover letter must be written and submitted by corresponding author. Please check the cover letter template here. Authors can either download the template, edit and submit or type their own letter. E-signature is acceptable.

Cover letter should be submitted along with the manuscript.

Abstract should not exceed 300 words. Provide 3 to 6 keywords.

Graphical abstract is not compulsory but encouraged to submit. Chief editor might inform the author(s) to submit the graphical abstract if its required for the manuscript. High resolution and clear graphical abstract should be place right after the abstract in the manuscript. Graphical abstract should be pictorial with limited words. The acceptable format is .jpg, .jpeg, .tiff.

Figures should be clearly structured with fewer words. Only high-resolution images with minimum of 300 dpi are accepted and the low-resolution images send back to the authors for improvements. Both figure caption and legends are required. Figure should be novel and not copied from previously published journal. Incase if authors used any images from the previously published article, then prior approval should be taken and mentioned in the manuscript where it is required. Failure to do may lead to removal of figure from the manuscript. Figure(s) should be placed right after the required statement and cited in the manuscript with proper figure number (s). Ex: (Figure 1)

Figure Format: .jpg, .jpeg, .tiff

Table(s) should be uploaded separately. Table(s) must have a clear information with proper citation wherever it is required. Table(s) title should be mentioned. Table(s) should not have a paragraph wise statement. Table(s) should be placed right after the required statement and cited in the manuscript with table number, Ex (Table 1). If any abbreviations used in the table, then the full form of the abbreviations should be included below the table(s).

Authors are required to mention the animal ethical statement along with the approval number and name of the organization. If ethical approval is not required, then authors should mention the statement “Not applicable”.

Patients have a right to privacy thus; all studies should be conducted with informed consent. No identifying information should be published in written descriptions, photographs, and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. When informed consent has been obtained, it should be indicated in the article. Investigations with human subjects must follow the ethical standards formulated in the Helsinki Declaration of 1964, revised in 2013. All the experiments should be approved by the institutional human experimentation committee or equivalent.

The journal recommends that the clinical trials should be registered in a publicly accessible database. Authors should include the clinical trial registration numbers on all papers that report their results. The authors must adhere to the minimum set of recommendations for reporting randomized trials as described in "The CONSORT (CONsolidated Standards of Reporting Trials) guideline".

Big Science Publishers follows ICMJE regulation to report any conflict of interest https://www.icmje.org/recommendations/browse/roles-and-responsibilities/author-responsibilities--conflicts-of-interest.html. Corresponding author must fill and upload the ICMJE disclosure form (Click here to download the form) along with the manuscript even though there is no conflict of interest. Also, conflict of interest statement should be mentioned in the manuscript under conflict of interest section. If there is no conflict of interest, then authors should mention “There is no conflict of interest”.

Authors should provide the source of funding to perform this work and/or publish this manuscript. Funding details should be mentioned with the name of the agency/institute, approval number with month and year. If no funding has received, the following statement should be included under the funding section

‘This review work did not receive any funding or specific grants from any agency/institute in the public, commercial, or not-for-profit sectors’.

Acknowledgements should be mentioned before reference section in the manuscript. Acknowledgements may include a support of funding, free sample, or any other related work contributed for the manuscript. Contributors those who did not meet the requirements for the authorship can be included here under acknowledgement.

Title of the article and all the headings like Abstract, Introduction etc should be 12 and subheading and content of the article should be 10 in size. Keep Times New Roman font style throughout the article.

Authors should carefully check the name, spelling and order of the authors name(s) before submission. In case, any correction/addition/removal in the author’s name should be communicated via corresponding author to the journal editorial office through mail. Authors will be having the chance to update the corrections till release of the final proofread. None of the corrections will be accepted once the article published in the online.

Authors are advised to suggest the potential reviewers. Authors should choose the reviewers according to the main focus of the article. Also, reviewers should not be your colleagues/same institution/have competing interest. Authors should suggest the reviewers from other institution/country/region, and make sure that there should not be any contact between any of the authors and the reviewers for at least 5 years.

Authors should not choose the reviewers from this journal editorial members. However, chief editor will finalize the selection of the reviewers after careful analysis.

Abbreviations should be clearly explained at first place where mentioned. Try to avoid using abbreviations in the title/ abstract. Manuscript will be reverted back to the authors if any unexplained abbreviation found and that may affect delay in the publications.

Authors must fill and upload the “Author Agreement and Journal Copyright Form” along with the manuscript Click here for the template.

Published articles in Reviews in Pharmaceutical Sciences are distributed under creative common license (CC-BY 4.0). Read the information here https://creativecommons.org/licenses/by/4.0/

The journal allows the authors to hold the copyright of work and do not need to provide the copyright to the journal. However, the authors grant the permission and licence to publish the article and identify itself as the original publisher.

Journal allows author to self-archive, pre-print, post-print, proof-read and final published version of the article in any OAI-compliant repository.

Authors and readers can send their complaints/queries to the email address chiefeditor.rps@outlook.com. All the complaints/queries will receive a response within 48 hours.

The journal does not accept any commercial advertisements. Other than commercial advertisements, our advertising policy follows the principles mentioned in the Recommendations on Publication Ethics Policies for Medical Journals issued by the World Association of Medical Editors (WAME).

If any minor error(s) or correction(s) identified in the published articles, journal may contact the editors and the authors or authors institutions. Errors by the journal or authors may be resolved by erratum or corrigendum. If there is any significant error found in the published article may lead to retraction or demand an explanation. Reviews in Pharmaceutical Sciences follows COPE retraction guidelines https://doi.org/10.24318/cope.2019.1.4

All content published in Reviews in Pharmaceutical Sciences is archived in Zenodo, an open-access repository operated by CERN, to support its long-term preservation and accessibility for scholars, researchers, and students.

If any breaches in our publication ethics policy suspected before or after publication should be reported to the journal. Claimants will be kept anonymous if requested.

As soon as we receive the misconduct information, journal editors will immediately start the investigation. Editor asks for an additional data, figures, supplementary files etc related to the misconduct reported. Journal might contact the authors institutions.

If an article found to violate the journal policies will be rejected immediately from the journal site or retracted based on the misconduct severity.

However, if it is a minor issue, authors may be informed to correct the error by corrigendum and journals by erratum.

Reviews in Pharmaceutical Sciences follows COPE flowcharts to deal with any misconduct https://publicationethics.org/guidance/Flowcharts

In addition to that, journal may take the following, 

Reviews in Pharmaceutical Sciences is a fully open access journal. The published articles will be freely available for the readers without any registration, subscription or payment.

Also, the journal encourage the authors for self-archiving the published articles in any OAI-compliant or subject based repository.

All the published articles are licensed under a Creative Commons License (CC-BY), full details of which can be found here.

Initial Scrutiny

Once the author submits the manuscript to the journal, chief editor/ expert editors will check the manuscript whether the manuscript meets the journal requirements and guidelines such as language, figure clarity, plagiarism, references, ethics, manuscript structure.

Insufficient originality, language error, not following the journal guidelines may lead to rejection without proceeding for the peer review. Manuscript with minor errors may considered for the peer review process once the errors has been corrected.

Peer review

Manuscript passed for the initial scrutiny will send to the peer review process. Minimum of two experts from the field of study(whose identities will remain anonymous to the authors) will thoroughly check the study integrity.

Reviewers can be suggested by the authors. Please note that the suggested reviewers should have an extensive knowledge in the field of study with good academic background and publications. However, authors should not have a direct or indirect contact with the suggested reviewers. Editor-in-Chief may consider the suggested reviewer for the peer review process and reserve the rights not to consider the list of suggested reviewers.

Editorial Review and Decision

Expert reviewers’ comments will be carefully analysed by the Chief Editor. Chief Editor decision is final on the manuscript revision or acceptance or rejection.

Chief Editor will communicate minor/ major corrections to the authors.

Authors must address all the comments with clarity. Pointwise reason/ clarification is required with the rebuttal document.

Authors should strictly follow the timeline for the revision and resubmission. If authors fail to submit within the time limit, the manuscript may not be considered for publication.

Proof-read and Publications

Proof-read of the accepted manuscript will send to the corresponding author for final approval.

Corresponding author should carefully check the manuscript and approve the proof-read copy within the time limit.

None of the corrections will be considered once the proof-read is approved.

Authors should ensure the originality of the manuscript. It is authors responsibility to check the plagiarism before submitting to the journal for publications. During screening process, if plagiarism detected, the manuscript will be rejected immediately. Moreover, in case authors used any work of others must be acknowledged properly in the manuscript.

If the plagiarism reported after publication may lead to permanent manuscript retraction from the journal and informed to the author, co-authors, funding agencies, and institution accordingly.

Authors may use AI-assisted tools for language, grammar, formatting, or readability improvement, but they remain fully responsible for the accuracy, originality, integrity, and validity of the submitted work. Any generative AI use that contributes to literature review, data analysis, coding, images, figures, methods, results, or conclusions, references, must be clearly disclosed in the manuscript. AI tools must not be listed as authors and must not be used to fabricate data, citations, images, peer-review reports, or editorial decisions.

ICMJE AI Guidelines:

COPE AI Policy: